Should I buy or sell Cardinal Health stock right now?

9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cardinal Health in the last year. There are currently 6 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CAH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CAH, but not buy additional shares or sell existing shares. View CAH analyst ratings or view top-rated stocks .

What is Cardinal Health's stock price target for 2024?

9 brokers have issued 12 month price objectives for Cardinal Health's shares. Their CAH share price targets range from $85.00 to $112.00. On average, they expect the company's share price to reach $96.83 in the next year. This suggests that the stock has a possible downside of 8.7%. View analysts price targets for CAH or view top-rated stocks among Wall Street analysts .

How have CAH shares performed in 2023?

Cardinal Health's stock was trading at $76.87 at the beginning of 2023. Since then, CAH stock has increased by 38.0% and is now trading at $106.06. View the best growth stocks for 2023 here .

Are investors shorting Cardinal Health?

Cardinal Health saw a increase in short interest during the month of November. As of November 15th, there was short interest totaling 8,210,000 shares, an increase of 18.5% from the October 31st total of 6,930,000 shares. Based on an average daily trading volume, of 2,090,000 shares, the short-interest ratio is presently 3.9 days. Currently, 3.4% of the shares of the stock are short sold. View Cardinal Health's Short Interest .

When is Cardinal Health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 1st 2024. View our CAH earnings forecast .

How were Cardinal Health's earnings last quarter?

Cardinal Health, Inc. (NYSE:CAH) issued its quarterly earnings results on Friday, November, 3rd. The company reported $1.73 earnings per share for the quarter, topping the consensus estimate of $1.40 by $0.33. The firm had revenue of $54.76 billion for the quarter, compared to the consensus estimate of $54.85 billion. Cardinal Health had a net margin of 0.07% and a negative trailing twelve-month return on equity of 60.27%. Cardinal Health's revenue for the quarter was up 10.4% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.20 earnings per share. Read the conference call transcript .

How often does Cardinal Health pay dividends? What is the dividend yield for Cardinal Health?

Cardinal Health declared a quarterly dividend on Tuesday, November 14th. Shareholders of record on Tuesday, January 2nd will be given a dividend of $0.5006 per share on Monday, January 15th. This represents a $2.00 annualized dividend and a yield of 1.89%. The ex-dividend date is Friday, December 29th. Read our dividend analysis for CAH .

Is Cardinal Health a good dividend stock?

Cardinal Health (NYSE:CAH) pays an annual dividend of $2.00 per share and currently has a dividend yield of 1.87%. The company has been increasing its dividend for 27 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 327.87%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, CAH will have a dividend payout ratio of 26.04% next year. This indicates that the company will be able to sustain or increase its dividend. Read our dividend analysis for CAH .

What ETFs hold Cardinal Health's stock?

ETFs with the largest weight of Cardinal Health (NYSE:CAH) stock in their portfolio include USCF Dividend Income Fund (UDI) , First Trust Nasdaq Pharmaceuticals ETF (FTXH) , WBI BullBear Yield 3000 ETF (WBIG) , BlackRock Large Cap Value ETF (BLCV) , LeaderShares AlphaFactor Tactical Focused ETF (LSAT) , SEI Enhanced U.S. Large Cap Value Factor ETF (SEIV) , First Trust Dorsey Wright Momentum & Value ETF (DVLU) and Invesco Bloomberg MVP Multi-factor ETF (PWC) .

What guidance has Cardinal Health issued on next quarter's earnings?

Cardinal Health issued an update on its FY24 earnings guidance on Friday, November, 3rd. The company provided earnings per share guidance of $6.75-7.00 for the period, compared to the consensus EPS estimate of $6.68.

What is Mike Kaufmann's approval rating as Cardinal Health's CEO?

357 employees have rated Cardinal Health Chief Executive Officer Mike Kaufmann on Glassdoor.com . Mike Kaufmann has an approval rating of 85% among the company's employees.

What other stocks do shareholders of Cardinal Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cardinal Health investors own include AbbVie (ABBV) , AT&T (T) , Johnson & Johnson (JNJ) , CVS Health (CVS) , Exxon Mobil (XOM) , Pfizer (PFE) , Chevron (CVX) , Intel (INTC) , Cisco Systems (CSCO) and PepsiCo (PEP) .

Who are Cardinal Health's major shareholders?

Cardinal Health's stock is owned by a number of institutional and retail investors. Top institutional shareholders include FMR LLC (2.42%), Morgan Stanley (1.79%), Ameriprise Financial Inc. (1.67%), Invesco Ltd. (1.41%), Northern Trust Corp (1.36%) and Acadian Asset Management LLC (1.03%). Insiders that own company stock include Deborah Weitzman , Jessica L Mayer , Mary C Scherer, Michelle Brennan , Ola M Snow and Stephen M Mason . View institutional ownership trends .

How do I buy shares of Cardinal Health?

Shares of CAH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull , Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here .

Does Cardinal Health have any subsidiaries?

The following companies are subsidiares of Cardinal Health: A+ Secure Packaging LLC, Access Closure, Aero-Med LLC, Alaris Medical Systems, Allegiance Corporation, Allegiance Healthcare, AssuraMed, Automatic Liquid Packaging, Bergen Brunswig Corp, Bindley Western Industries, Blue Robin LLC, Boron LePore & Associates, Borschow Hospital & Medical Supplies, Cardinal Health 100 LLC, Cardinal Health 104 LP, Cardinal Health 105 LLC, Cardinal Health 107 LLC, Cardinal Health 108 LLC, Cardinal Health 110 LLC, Cardinal Health 112 LLC, Cardinal Health 113 LLC, Cardinal Health 114 Inc., Cardinal Health 115 LLC, Cardinal Health 116 LLC, Cardinal Health 118 LLC, Cardinal Health 119 LLC, Cardinal Health 121 LLC, Cardinal Health 122 LLC, Cardinal Health 123 LLC, Cardinal Health 124 LLC, Cardinal Health 126 LLC, Cardinal Health 127 Inc., Cardinal Health 132 LLC, Cardinal Health 2 LLC, Cardinal Health 200 LLC, Cardinal Health 201 LLC, Cardinal Health 222 (Thailand) Ltd., Cardinal Health 247 Inc., Cardinal Health 249 LLC, Cardinal Health 3 LLC, Cardinal Health 414 LLC, Cardinal Health 5 LLC, Cardinal Health 6 Inc., Cardinal Health 7 LLC, Cardinal Health Australia 503 Pty. Ltd., Cardinal Health Austria 504 GmbH, Cardinal Health Belgium 505 BVBA, Cardinal Health Canada Holdings Cooperative U.A., Cardinal Health Canada Inc., Cardinal Health Chile Limitada, Cardinal Health Colombia S.A.S., Cardinal Health D.R. 203 II Ltd., Cardinal Health Denmark ApS, Cardinal Health Finland Oy, Cardinal Health Foundation, Cardinal Health France 506 SAS, Cardinal Health Funding LLC, Cardinal Health Germany 507 GmbH, Cardinal Health Germany Manufacturing GmbH, Cardinal Health IPS LLC, Cardinal Health International India Private Limited, Cardinal Health International Philippines Inc., Cardinal Health Ireland 419 Designated Activity Company, Cardinal Health Ireland 508 Limited, Cardinal Health Ireland Unlimited Company, Cardinal Health Italy 509 Srl, Cardinal Health Japan G.K., Cardinal Health K.K., Cardinal Health Korea Limited, Cardinal Health Malaysia 211 Sdn. Bhd., Cardinal Health Malta 212 Limited, Cardinal Health Managed Care Services LLC, Cardinal Health Medical Equipment Consulting (Shanghai) Co. Ltd., Cardinal Health Mexico 514 S. de R.L. de C.V., Cardinal Health Middle East FZ-LLC, Cardinal Health Netherlands 502 B.V., Cardinal Health P.R. 120 Inc., Cardinal Health P.R. 218 Inc., Cardinal Health P.R. 220 LLC, Cardinal Health Pharmaceutical Contracting LLC, Cardinal Health Pharmacy Services LLC, Cardinal Health Singapore 225 Pte. Ltd., Cardinal Health Spain 511 S.L., Cardinal Health Sweden 512 A.B., Cardinal Health Switzerland 515 GmbH, Cardinal Health Systems Inc., Cardinal Health Technologies LLC, Cardinal Health Technologies Switzerland GmbH, Cardinal Health U.K. 432 Limited, Cardinal Health do Brasil Ltd., CareFusion, Cirpro de Delicias S.A. de C.V., Convertors de Mexico S.A. de C.V., Cordis, Cordis (Shanghai) Medical Devices Co. Ltd., Cordis Corporation, Cornerstone Rheumatology L.P., Covidien Manufacturing Solutions S.A., Denver Biomedical, Dik Drug, EPIC Insurance Company, Emerge Medical, Enturia, Especialidades Medicas Kenmex S.A. de C.V., Futuremed Health Care Products, Gala Biotech, Geodax Technology, GetOutcomes LLC, Griffin Capital LLC, HLS Freight Services, Healthcare Solutions Holding, Innovative Therapies LLC, Instant Diagnostic Systems Inc., KPR Australia Pty. Ltd., KPR U.S. LLC, Kendall-Gammatron Limited, Kinray, Leader Drugstores Inc., Ludlow Technical Products Canada Ltd., MCD, Magellan Laboratories, Marin Apothecaries, MedMined, Medicine Shoppe International Inc., Medicine Shoppe International Inc., Mediquip Sdn. Bhd., Mirixa Corporation, Mirixa Corporation, MosaicGPO LLC, Mscripts, NaviHealth, One Cloverleaf LLC, Outcomes Incorporated, Outcomes Incorporated, Owen Healthcare, PCI Pharma Services, ParMed Pharmaceuticals, Patient Recovery Business of Medtronic, Pinnacle Intellectual Property Services Inc., Pinnacle Intellectual Property Services-International Inc., Pyxis Corporation, Quiroproductos de Cuauhtemoc S. de R.L. de C.V., R.P. Scherer Corporation, RGH Enterprises LLC, RainTree GPO LLC, RainTree Oncology Services, Renal Purchasing Group LLC, Rxealtime Inc., Sonexus Health LLC, Syncor International, TelePharm, TelePharm LLC, The Harvard Drug Group, The Harvard Drug Group L.L.C., Traverse GPO LLC, Viasys Healthcare, WaveMark Inc., Zuellig Pharma China, and mscripts LLC. Read More

Cardinal Health Stock Price, News & Analysis (NYSE:CAH)

$106.55

+0.17 (+0.16%)

(As of 02:21 PM ET)

Compare

Today's Range: $105.67
▼
$106.98
50-Day Range: $86.38
▼
$107.46
52-Week Range: $68.53
▼
$108.03

Volume: 456,075 shs
Average Volume: 2.27 million shs
Market Capitalization: $26.26 billion

P/E Ratio: 174.67
Dividend Yield: 1.88%
Price Target: $96.83

Cardinal Health MarketRank™ Stock Analysis

Analyst Rating: Hold
2.33 Rating Score
Upside/Downside: 8.7% Downside
$96.83 Price Target
Short Interest: Healthy
3.35% of Float Sold Short
Dividend Strength: Strong
Based on Four Factors
Sustainability: -2.65
Upright™ Environmental Score
News Sentiment: 0.82
Based on 10 Articles This Week
Insider Trading: Selling Shares
$3.90 M Sold Last Quarter
Proj. Earnings Growth: 11.47%
From $6.89 to $7.68 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.29 out of 5 stars

Medical Sector

264th out of 960 stocks

Drugs, Proprietaries, & Sundries Industry

3rd out of 5 stocks

1.2

Analyst's Opinion

Consensus Rating
Cardinal Health has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 3 buy ratings, 6 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $96.83, Cardinal Health has a forecasted downside of 8.7% from its current price of $106.06.
Amount of Analyst Coverage
Cardinal Health has only been the subject of 1 research reports in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
3.35% of the float of Cardinal Health has been sold short.
Short Interest Ratio / Days to Cover
Cardinal Health has a short interest ratio ("days to cover") of 3.9, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Cardinal Health has recently increased by 18.47%, indicating that investor sentiment is decreasing significantly.

3.3

Dividend Strength

Dividend Yield
Cardinal Health pays a meaningful dividend of 1.87%, higher than the bottom 25% of all stocks that pay dividends.
Dividend Growth
Cardinal Health has been increasing its dividend for 27 years.
Dividend Coverage
The dividend payout ratio of Cardinal Health is 327.87%. Payout ratios above 75% are not desirable because they may not be sustainable.
Dividend Sustainability
Based on earnings estimates, Cardinal Health will have a dividend payout ratio of 26.04% next year. This indicates that Cardinal Health will be able to sustain or increase its dividend.

3.6

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Cardinal Health has received a 44.99% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Wholesale of antisera and vaccines", "Wholesale of cancer medication", "Wholesale of rheumatoid medication", and "Wholesale of immunosupressive medication" products. See details.
Environmental Sustainability
The Environmental Impact score for Cardinal Health is -2.65.

3.2

News and Social Media Coverage

News Sentiment
Cardinal Health has a news sentiment score of 0.82. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.52 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 10 news articles for Cardinal Health this week, compared to 8 articles on an average week.
Search Interest
Only 23 people have searched for CAH on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
MarketBeat Follows
7 people have added Cardinal Health to their MarketBeat watchlist in the last 30 days. This is an increase of 17% compared to the previous 30 days.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Cardinal Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $3,895,411.00 in company stock.
Percentage Held by Insiders
Only 0.15% of the stock of Cardinal Health is held by insiders.
Percentage Held by Institutions
86.01% of the stock of Cardinal Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.9

Earnings and Valuation

Earnings Growth
Earnings for Cardinal Health are expected to grow by 11.47% in the coming year, from $6.89 to $7.68 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Cardinal Health is 173.87, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 120.69.
Price to Earnings Ratio vs. Sector
The P/E ratio of Cardinal Health is 173.87, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 130.63.
Price to Earnings Growth Ratio
Cardinal Health has a PEG Ratio of 1.02. PEG Ratios around 1 indicate that a company is correctly valued.

See Top Rated MarketRank™ Stocks Here

About Cardinal Health Stock (NYSE:CAH)

Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

CAH Stock Price History

30 days | 90 days | 365 days | Advanced Chart

CAH Stock News Headlines

November 28, 2023 | marketbeat.com

Teva Pharma is the way to play the re-rise of generic drugs (CAH)

Generic and specialty pharmaceutical company, Teva Pharmaceutical's stock, has underperformed for years, but a potential spinoff may be a catalyst for growth

December 7, 2023 | usatoday.com

Cardinal Health Issues Medical Device Recall for Nurse Assist Products Contained Within Kits/Trays

December 8, 2023 | Edge On The Street (Ad)

Energy Storage Trend Ignites Frenzy Over Vanadium Supply

As the world shifts to renewables such as wind and solar, how will we store all this energy? Vanadium batteries are the breakthrough that some experts predict will be the future of grid-scale energy storage. The problem is, only 5% of vanadium is mined in the U.S. - and China and Russia have a stranglehold on our supply.

December 4, 2023 | finance.yahoo.com

McKesson (MCK) Announces Availability of FDA-Cleared Drug

December 2, 2023 | americanbankingnews.com

Cardinal Health, Inc. (NYSE:CAH) CEO Deborah Weitzman Sells 36,642 Shares

December 1, 2023 | reuters.com

US FDA says BD is recalling infusion pumps due to compatibility issues

November 29, 2023 | finance.yahoo.com

Insider Sell: CEO Deborah Weitzman Offloads Shares of Cardinal Health Inc

November 27, 2023 | msn.com

Cardinal Health (CAH) Price Target Increased by 10.03% to 110.93

December 8, 2023 | Edge On The Street (Ad)

Energy Storage Trend Ignites Frenzy Over Vanadium Supply

November 27, 2023 | finance.yahoo.com

Cardinal Health, Inc. (CAH) Hits Fresh High: Is There Still Room to Run?

November 24, 2023 | finance.yahoo.com

3 Reasons Why Growth Investors Shouldn't Overlook Cardinal (CAH)

November 24, 2023 | finance.yahoo.com

Cardinal Health (CAH) Gets FDA Warning for Monoject Syringes

November 21, 2023 | finance.yahoo.com

Nevro's (NVRO) New Data Supports SCS Therapy for NSRBP Treatment

November 21, 2023 | msn.com

FDA warns on using Cardinal Health Monoject syringes with certain pumps

November 20, 2023 | stocknews.com

3 Medical Stocks Elevating Investors' Profit Potential

November 20, 2023 | finance.yahoo.com

UPDATE 2-FDA warns against using Cardinal's syringes

November 20, 2023 | msn.com

FDA warns against using Cardinal's syringes, pain-control pumps

November 17, 2023 | markets.businessinsider.com

JP Morgan Maintains Neutral Rating for Cardinal Health: Here's What You Need To Know

November 16, 2023 | finance.yahoo.com

Zacks.com featured highlights Cboe Global, Parker-Hannifin, Microsoft, FedEx and Cardinal Health

November 14, 2023 | msn.com

Cardinal Health issues product correction recall for syringes

November 10, 2023 | msn.com

Cardinal Health (CAH) Launches Surgical Gown for Safe Surgery

November 9, 2023 | finance.yahoo.com

Cardinal Health launches SmartGown™ EDGE Breathable Surgical Gown with ASSIST™ Instrument Pockets

November 8, 2023 | theglobeandmail.com

3 Dividend Aristocrats Beating the Market in 2023

November 8, 2023 | finance.yahoo.com

Cardinal Health, Inc. (CAH) Hit a 52 Week High, Can the Run Continue?

November 7, 2023 | finance.yahoo.com

Is Cardinal (CAH) a Solid Growth Stock? 3 Reasons to Think "Yes"

November 6, 2023 | bizjournals.com

Covid-19 vaccines help Cardinal beat quarterly expectations, raise FY24 guidance

November 3, 2023 | finance.yahoo.com

Q1 2024 Cardinal Health Inc Earnings Call

See More Headlines

Receive CAH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cardinal Health and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 10/15 Dividend: 10/02/2023
Dividend Payable: 10/15/2023
Last Earnings: 11/03/2023
Today: 12/08/2023
Ex-Dividend for 1/15 Dividend: 12/29/2023
Dividend Payable: 1/15/2024
Next Earnings (Estimated): 2/01/2024
Fiscal Year End: 6/30/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Drugs, proprietaries, & sundries
Sub-Industry: Health Care Distributors
Sector: Medical
Current Symbol: NYSE:CAH
CUSIP: 14149Y10
CIK: 721371
Web: www.cardinalhealth.com
Phone: (614) 757-5000
Fax: 614-757-6000
Employees: 48,000
Year Founded: 1971

Price Target and Rating

Average Stock Price Target: $96.83
High Stock Price Target: $112.00
Low Stock Price Target: $85.00
Potential Upside/Downside: -8.7%
Consensus Rating: Hold
Rating Score (0-4): 2.33
Research Coverage: 9 Analysts

Profitability

EPS (Most Recent Fiscal Year): $0.61
Trailing P/E Ratio: 173.85
Forward P/E Ratio: 15.39
P/E Growth: 1.02
Net Income: $261 million
Net Margins: 0.07%
Pretax Margin: 0.24%
Return on Equity: -60.27%
Return on Assets: 3.71%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 0.99
Quick Ratio: 0.50

Sales & Book Value

Annual Sales: $210.17 billion
Price / Sales: 0.12
Cash Flow: $8.59 per share
Price / Cash Flow: 12.34
Book Value: ($11.20) per share
Price / Book: -9.47

Miscellaneous

Outstanding Shares: 246,468,000
Free Float: 246,098,000
Market Cap: $26.14 billion
Optionable: Optionable
Beta: 0.80

Social Links

Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

Mr. Jason M. Hollar (Age 50)
CEO & Director
Comp: $3.95M
Mr. Aaron E. Alt (Age 50)
Chief Financial Officer
Comp: $2.19M
Ms. Jessica L. Mayer (Age 53)
Chief Legal & Compliance Officer
Comp: $1.48M
Mr. Stephen M. Mason (Age 51)
Chief Executive Officer of Medical Segment
Comp: $1.23M
Ms. Deborah L. Weitzman (Age 58)
Chief Executive Officer of Pharmaceutical Segment
Comp: $1.4M
Ms. Patricia M. English (Age 43)
Senior Vice President
Comp: $451.34k
Ms. Mary C. Scherer
Senior VP & Chief Accounting Officer
Ms. Michelle D. Greene (Age 53)
Executive VP, Chief Information Officer & Customer Support Services
Matt Sims
Vice President of Investor Relations
Ms. Ola M. Snow (Age 55)
Chief Human Resources Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

Should I Buy Cardinal Health Stock? CAH Pros and Cons Explained

These insights were generated using artificial intelligence. They are based on proprietary MarketBeat data, news articles, and custom LLM A.I. algorithms. This analysis of Cardinal Health was last updated on Tuesday, November 28, 2023 at 1:34 PM.

Pros

Here are some ways that investors could benefit from investing in Cardinal Health, Inc.:

Recent developments in the healthcare industry, such as the crackdown on 'below radar' deals by FTC Chair Lina Khan, could create more competition in the market and potentially benefit Cardinal Health, Inc.
Cardinal Health, Inc. has a strong track record of industry diversification and innovation, which supports future growth prospects.
Investors may find the current stock price of Cardinal Health, Inc. attractive, providing a potential opportunity for investment.
Cardinal Health, Inc. operates in the healthcare sector, which is known for its stability and long-term growth potential.
Recent developments in Medicare price negotiations could impact pharmaceutical stocks positively, and Cardinal Health, Inc. may benefit from this trend.

Cons

Investors should be bearish about investing in Cardinal Health, Inc. for these reasons:

There may be potential risks associated with the healthcare industry, such as regulatory changes and market uncertainties.
Investors should consider the potential impact of any future developments in Medicare price negotiations on Cardinal Health, Inc.'s financial performance.
Market conditions and competition within the healthcare sector could affect Cardinal Health, Inc.'s market share and profitability.
Investors should carefully evaluate the company's financial health and performance, including factors such as revenue growth, profitability, and debt levels.
It is important to consider the potential impact of any future regulatory actions or investigations on Cardinal Health, Inc.'s operations and reputation.

CAH Stock Analysis - Frequently Asked Questions

Should I buy or sell Cardinal Health stock right now?: 9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cardinal Health in the last year. There are currently 6 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CAH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CAH, but not buy additional shares or sell existing shares.
View CAH analyst ratings or view top-rated stocks.
What is Cardinal Health's stock price target for 2024?: 9 brokers have issued 12 month price objectives for Cardinal Health's shares. Their CAH share price targets range from $85.00 to $112.00. On average, they expect the company's share price to reach $96.83 in the next year. This suggests that the stock has a possible downside of 8.7%.
View analysts price targets for CAH or view top-rated stocks among Wall Street analysts.
How have CAH shares performed in 2023?: Cardinal Health's stock was trading at $76.87 at the beginning of 2023. Since then, CAH stock has increased by 38.0% and is now trading at $106.06.
View the best growth stocks for 2023 here.
Are investors shorting Cardinal Health?: Cardinal Health saw a increase in short interest during the month of November. As of November 15th, there was short interest totaling 8,210,000 shares, an increase of 18.5% from the October 31st total of 6,930,000 shares. Based on an average daily trading volume, of 2,090,000 shares, the short-interest ratio is presently 3.9 days. Currently, 3.4% of the shares of the stock are short sold.
View Cardinal Health's Short Interest.
When is Cardinal Health's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, February 1st 2024.
View our CAH earnings forecast.
How were Cardinal Health's earnings last quarter?: Cardinal Health, Inc. (NYSE:CAH) issued its quarterly earnings results on Friday, November, 3rd. The company reported $1.73 earnings per share for the quarter, topping the consensus estimate of $1.40 by $0.33. The firm had revenue of $54.76 billion for the quarter, compared to the consensus estimate of $54.85 billion. Cardinal Health had a net margin of 0.07% and a negative trailing twelve-month return on equity of 60.27%. Cardinal Health's revenue for the quarter was up 10.4% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.20 earnings per share.
Read the conference call transcript.
How often does Cardinal Health pay dividends? What is the dividend yield for Cardinal Health?: Cardinal Health declared a quarterly dividend on Tuesday, November 14th. Shareholders of record on Tuesday, January 2nd will be given a dividend of $0.5006 per share on Monday, January 15th. This represents a $2.00 annualized dividend and a yield of 1.89%. The ex-dividend date is Friday, December 29th.
Read our dividend analysis for CAH.
Is Cardinal Health a good dividend stock?: Cardinal Health (NYSE:CAH) pays an annual dividend of $2.00 per share and currently has a dividend yield of 1.87%. The company has been increasing its dividend for 27 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 327.87%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, CAH will have a dividend payout ratio of 26.04% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CAH.

What ETFs hold Cardinal Health's stock?: ETFs with the largest weight of Cardinal Health (NYSE:CAH) stock in their portfolio include USCF Dividend Income Fund (UDI), First Trust Nasdaq Pharmaceuticals ETF (FTXH), WBI BullBear Yield 3000 ETF (WBIG), BlackRock Large Cap Value ETF (BLCV), LeaderShares AlphaFactor Tactical Focused ETF (LSAT), SEI Enhanced U.S. Large Cap Value Factor ETF (SEIV), First Trust Dorsey Wright Momentum & Value ETF (DVLU) and Invesco Bloomberg MVP Multi-factor ETF (PWC).
What guidance has Cardinal Health issued on next quarter's earnings?: Cardinal Health issued an update on its FY24 earnings guidance on Friday, November, 3rd. The company provided earnings per share guidance of $6.75-7.00 for the period, compared to the consensus EPS estimate of $6.68.
What is Mike Kaufmann's approval rating as Cardinal Health's CEO?: 357 employees have rated Cardinal Health Chief Executive Officer Mike Kaufmann on Glassdoor.com. Mike Kaufmann has an approval rating of 85% among the company's employees.
What other stocks do shareholders of Cardinal Health own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Cardinal Health investors own include AbbVie (ABBV), AT&T (T), Johnson & Johnson (JNJ), CVS Health (CVS), Exxon Mobil (XOM), Pfizer (PFE), Chevron (CVX), Intel (INTC), Cisco Systems (CSCO) and PepsiCo (PEP).
Who are Cardinal Health's major shareholders?: Cardinal Health's stock is owned by a number of institutional and retail investors. Top institutional shareholders include FMR LLC (2.42%), Morgan Stanley (1.79%), Ameriprise Financial Inc. (1.67%), Invesco Ltd. (1.41%), Northern Trust Corp (1.36%) and Acadian Asset Management LLC (1.03%). Insiders that own company stock include Deborah Weitzman, Jessica L Mayer, Mary C Scherer, Michelle Brennan, Ola M Snow and Stephen M Mason.
View institutional ownership trends.
How do I buy shares of Cardinal Health?: Shares of CAH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
Does Cardinal Health have any subsidiaries?: The following companies are subsidiares of Cardinal Health: A+ Secure Packaging LLC, Access Closure, Aero-Med LLC, Alaris Medical Systems, Allegiance Corporation, Allegiance Healthcare, AssuraMed, Automatic Liquid Packaging, Bergen Brunswig Corp, Bindley Western Industries, Blue Robin LLC, Boron LePore & Associates, Borschow Hospital & Medical Supplies, Cardinal Health 100 LLC, Cardinal Health 104 LP, Cardinal Health 105 LLC, Cardinal Health 107 LLC, Cardinal Health 108 LLC, Cardinal Health 110 LLC, Cardinal Health 112 LLC, Cardinal Health 113 LLC, Cardinal Health 114 Inc., Cardinal Health 115 LLC, Cardinal Health 116 LLC, Cardinal Health 118 LLC, Cardinal Health 119 LLC, Cardinal Health 121 LLC, Cardinal Health 122 LLC, Cardinal Health 123 LLC, Cardinal Health 124 LLC, Cardinal Health 126 LLC, Cardinal Health 127 Inc., Cardinal Health 132 LLC, Cardinal Health 2 LLC, Cardinal Health 200 LLC, Cardinal Health 201 LLC, Cardinal Health 222 (Thailand) Ltd., Cardinal Health 247 Inc., Cardinal Health 249 LLC, Cardinal Health 3 LLC, Cardinal Health 414 LLC, Cardinal Health 5 LLC, Cardinal Health 6 Inc., Cardinal Health 7 LLC, Cardinal Health Australia 503 Pty. Ltd., Cardinal Health Austria 504 GmbH, Cardinal Health Belgium 505 BVBA, Cardinal Health Canada Holdings Cooperative U.A., Cardinal Health Canada Inc., Cardinal Health Chile Limitada, Cardinal Health Colombia S.A.S., Cardinal Health D.R. 203 II Ltd., Cardinal Health Denmark ApS, Cardinal Health Finland Oy, Cardinal Health Foundation, Cardinal Health France 506 SAS, Cardinal Health Funding LLC, Cardinal Health Germany 507 GmbH, Cardinal Health Germany Manufacturing GmbH, Cardinal Health IPS LLC, Cardinal Health International India Private Limited, Cardinal Health International Philippines Inc., Cardinal Health Ireland 419 Designated Activity Company, Cardinal Health Ireland 508 Limited, Cardinal Health Ireland Unlimited Company, Cardinal Health Italy 509 Srl, Cardinal Health Japan G.K., Cardinal Health K.K., Cardinal Health Korea Limited, Cardinal Health Malaysia 211 Sdn. Bhd., Cardinal Health Malta 212 Limited, Cardinal Health Managed Care Services LLC, Cardinal Health Medical Equipment Consulting (Shanghai) Co. Ltd., Cardinal Health Mexico 514 S. de R.L. de C.V., Cardinal Health Middle East FZ-LLC, Cardinal Health Netherlands 502 B.V., Cardinal Health P.R. 120 Inc., Cardinal Health P.R. 218 Inc., Cardinal Health P.R. 220 LLC, Cardinal Health Pharmaceutical Contracting LLC, Cardinal Health Pharmacy Services LLC, Cardinal Health Singapore 225 Pte. Ltd., Cardinal Health Spain 511 S.L., Cardinal Health Sweden 512 A.B., Cardinal Health Switzerland 515 GmbH, Cardinal Health Systems Inc., Cardinal Health Technologies LLC, Cardinal Health Technologies Switzerland GmbH, Cardinal Health U.K. 432 Limited, Cardinal Health do Brasil Ltd., CareFusion, Cirpro de Delicias S.A. de C.V., Convertors de Mexico S.A. de C.V., Cordis, Cordis (Shanghai) Medical Devices Co. Ltd., Cordis Corporation, Cornerstone Rheumatology L.P., Covidien Manufacturing Solutions S.A., Denver Biomedical, Dik Drug, EPIC Insurance Company, Emerge Medical, Enturia, Especialidades Medicas Kenmex S.A. de C.V., Futuremed Health Care Products, Gala Biotech, Geodax Technology, GetOutcomes LLC, Griffin Capital LLC, HLS Freight Services, Healthcare Solutions Holding, Innovative Therapies LLC, Instant Diagnostic Systems Inc., KPR Australia Pty. Ltd., KPR U.S. LLC, Kendall-Gammatron Limited, Kinray, Leader Drugstores Inc., Ludlow Technical Products Canada Ltd., MCD, Magellan Laboratories, Marin Apothecaries, MedMined, Medicine Shoppe International Inc., Medicine Shoppe International Inc., Mediquip Sdn. Bhd., Mirixa Corporation, Mirixa Corporation, MosaicGPO LLC, Mscripts, NaviHealth, One Cloverleaf LLC, Outcomes Incorporated, Outcomes Incorporated, Owen Healthcare, PCI Pharma Services, ParMed Pharmaceuticals, Patient Recovery Business of Medtronic, Pinnacle Intellectual Property Services Inc., Pinnacle Intellectual Property Services-International Inc., Pyxis Corporation, Quiroproductos de Cuauhtemoc S. de R.L. de C.V., R.P. Scherer Corporation, RGH Enterprises LLC, RainTree GPO LLC, RainTree Oncology Services, Renal Purchasing Group LLC, Rxealtime Inc., Sonexus Health LLC, Syncor International, TelePharm, TelePharm LLC, The Harvard Drug Group, The Harvard Drug Group L.L.C., Traverse GPO LLC, Viasys Healthcare, WaveMark Inc., Zuellig Pharma China, and mscripts LLC.
Read More

This page (NYSE:CAH) was last updated on 12/8/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial